Book a Meeting

Anti-CD5 Recombinant Immunotoxin (XMMLY-H65-RTA)

Cat#: BioBet-IT060Z
Target: CD5
Host: Mouse
Species Reactivity: Human

IT Type Antibody-based IT

Description The recombinant immunotoxin is comprised of an anti-Pan T-cell immunoglobulin, coupled to a cytotoxic agent, A chain of ricin.

Indication Cancer

Classification Immuntoxin; biobetter

Construction XMMLY-H65-RTA

Cooperation Seeking Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop our ADCC/CDC-enhanced antibodies or immutoxins. For commercial partners interested in our therapeutic biobetter product, Creative Biolabs welcomes collaboration.
Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.

Official Name CD5

Full Name CD5 Molecule

Background CD5 (CD5 Molecule) is a Protein Coding gene.
Diseases associated with CD5 include Thymus Cancer and Richter's Syndrome.
Among its related pathways are Hematopoietic Stem Cell Differentiation Pathways and Lineage-specific Markers and B Cell Development Pathways.
Gene Ontology (GO) annotations related to this gene include receptor activity and scavenger receptor activity.

Gene ID Entrez Gene: 921

UniProt ID UniProtKB: P06127

Antibody Clone XMMLY-H65

Biologic Classification Protein Based Therapies
Monoclonal antibody (mAb)

Antibody Type scFv

Antibody Indication Cancer

Toxic Moiety Ricin toxin A chain (RTA)

Organism Ricinus communis (Castor bean)

Family Ricin

Molecular Mass 30.1 kDa

Toxic MOA Ricin toxin A chain (RTA) is an N-glycoside hydrolase composed of 267 amino acids. Ricin is a toxalbumin, a biological toxin whose mechanism of action is inhibition of protein synthesis (manufacture of proteins) in eukaryotic cells; cell death results from the absence of proteins.

The antibody portion mediated selective binding to target cells, while the toxin portion mediated translocation into the cytosol and subsequent cell killing.

Cancer

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *

ISO 9001 Certified - Creative Biolabs Quality Management System.
© 2026 Creative Biolabs. All rights reserved.
Merry Christmas Merry Christmas